Rohan Palekar - Feb 17, 2022 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role: Chief Executive Officer, Director
Signature: /s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar
Stock symbol: ETNB
Transactions as of: Feb 17, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/22/2022, 04:06 PM
Previous filing: Apr 13, 2022
Next filing: Mar 4, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ETNB	Common Stock	Award	$0	+54.2K	+118.22%	$0.00	100K	Feb 17, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ETNB	Stock Option (Right to Buy)	Award	$0	+220K		$0.00	220K	Feb 17, 2022	Common Stock	220K	$4.44	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units that vest with respect to one-third of the underlying shares on February 17, 2023, with the remaining two-thirds vesting in equal semi-annual installments over the following two years, subject to the Reporting Person's continued service to the Issuer.
F2	This option represents a right to purchase a total of 220,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 17, 2023, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.